epilim cr
sanofi-aventis new zealand limited - sodium valproate 199.8mg; valproic acid 87mg (as navalproate 100.3mg) - modified release tablet - 300 mg - active: sodium valproate 199.8mg valproic acid 87mg (as navalproate 100.3mg) excipient: erythrosine ethylcellulose hydrated silica hypromellose indigo carmine iron oxide black propylene glycol purified water titanium dioxide - epilepsy: primary generalised epilepsy (petit mal absences, various forms of myoclonic epilepsy and tonic-clonic grand mal seizures). partial (focal) epilepsy either alone or as adjuvant therapy.
epilim ec
pharmacy retailing (nz) ltd t/a healthcare logistics - sodium valproate 200mg; sodium valproate 200mg; sodium valproate 200mg - modified release tablet - 200 mg - active: sodium valproate 200mg excipient: calcium silicate citric acid diethyl phthalate hypromellose macrogol 6000 magnesium stearate opaspray violet k-1-4613 polyvinylacetate phthalate povidone purified talc stearic acid active: sodium valproate 200mg excipient: calcium silicate citric acid diethyl phthalate hypromellose macrogol 6000 magnesium stearate opaspray polyvinylacetate phthalate povidone purified talc stearic acid active: sodium valproate 200mg excipient: calcium silicate magnesium stearate povidone purified talc violet enteric coat excipient blend violet sub-coat excipient blend - epilepsy: primary generalised epilepsy (petit mal absences, various forms of myoclonic epilepsy and tonic-clonic grand mal seizures). partial (focal) epilepsy either alone or as adjuvant therapy.
epilim ec
pharmacy retailing (nz) ltd t/a healthcare logistics - sodium valproate 500mg; sodium valproate 500mg; sodium valproate 500mg - modified release tablet - 500 mg - active: sodium valproate 500mg excipient: calcium silicate citric acid diethyl phthalate hypromellose macrogol 6000 magnesium stearate opaspray polyvinylacetate phthalate povidone purified talc stearic acid active: sodium valproate 500mg excipient: calcium silicate citric acid diethyl phthalate hypromellose macrogol 6000 magnesium stearate opaspray polyvinylacetate phthalate povidone purified talc stearic acid active: sodium valproate 500mg excipient: calcium silicate magnesium stearate povidone purified talc violet enteric coat excipient blend violet sub-coat excipient blend - epilepsy: primary generalised epilepsy (petit mal absences, various forms of myoclonic epilepsy and tonic-clonic grand mal seizures). partial (focal) epilepsy either alone or as adjuvant therapy.
epilim liquid
pharmacy retailing (nz) ltd t/a healthcare logistics - sodium valproate 40 mg/ml; - oral solution - 200 mg/5ml - active: sodium valproate 40 mg/ml excipient: cherry flavour 17.40.0740 citric acid hyetellose ponceau 4r purified water saccharin sodium sodium methyl hydroxybenzoate sodium propyl hydroxybenzoate sorbitol - epilepsy: primary generalised epilepsy (petit mal absences, various forms of myoclonic epilepsy and tonic-clonic grand mal seizures). partial (focal) epilepsy either alone or as adjuvant therapy.
spasmium comp. 500 mg/ml + 4 mg/ml solution for injection
richter pharma ag - hyoscine butylbromide, metamizole sodium monohydrate - solution for injection - neurological agent muscle relaxant - cattle, dogs, horses, pigs
sympagesic 500 mg/ml + 4 mg/ml solution for injection for horses, cattle, pigs and dogs
dechra regulatory bv - hyoscine butylbromide, metamizole sodium monohydrate - solution for injection - neurological agent muscle relaxant - cattle, dogs, horses, pigs
spasmium comp. 500 mg/ml + 4 mg/ml solution for injection
vetviva richter gmbh - hyoscine butylbromide, metamizole sodium monohydrate - solution for injection - neurological agent muscle relaxant - cattle, dogs, horses, pigs
optalgin drops
teva pharmaceutical industries ltd, israel - dipyrone - drops - dipyrone 500 mg/ml - metamizole sodium - metamizole sodium - relief of moderate to severe pain as in headache, toothache, dysmenorrhea andfor high fever that does not respond to other measures.
buscopan compositum ad us. vet 500 mg/ml - 4 mg/ml inj. sol. i.v./s.c. vial
boehringer ingelheim vetmedica gmbh - butylhyoscine bromide 4 mg/ml - eq. butylhyoscine 32,743 mg/ml; metamizole sodium 500 mg/ml - solution for injection - 500 mg/ml - 4 mg/ml - butylhyoscine bromide 4 mg/ml; metamizole sodium 500 mg/ml - butylscopolamine - cattle; dog; horse
valproate-aft
aft pharmaceuticals ltd - sodium valproate 100 mg/ml - solution for injection - 100 mg/ml - active: sodium valproate 100 mg/ml excipient: dibasic sodium phosphate dodecahydrate monobasic potassium phosphate water for injection - the treatment of patients with epilepsy or bipolar disorder, who would normally be maintained on oral sodium valproate, and for whom oral therapy is temporarily not possible.